Vicore Pharma Holding AB

NASDAQ:VCRE

Medical - Pharmaceuticals

Healthcare
$9.90 -1.66%

-$0.24 today

Market cap
$279.65M
Beta
0.15

Volume 0.00M

Average 0.26M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.22B

FY 2025 · Annual

Liabilities

$123.17M

FY 2025 · Annual

Equity

$1.10B

FY 2025 · Annual

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$44.2M
Short-term Investments$49.2M
Other Current$2.1M
Total Current Assets$95.5M
Other Non-current$388.7K
Total Non-current Assets$388.7K
Total Assets$95.9M

Analysis

Selected assets total $95.9M for Latest. The largest visible component is Short-term Investments at $49.2M, about 51.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingOct 22, 2026
SC 13GSC 13G filingOct 13, 2026
6-K6-K filingSep 30, 2026

How much cash does VCRE have?

Vicore Pharma Holding AB (VCRE) reported $578.15M in cash and equivalents in fiscal 2025.

How much debt does VCRE carry?

Vicore Pharma Holding AB (VCRE) reported $0.00 of total debt, with net debt of -$578.15M.